YZY BIO
YZY Bio is a biotechnology company that develops anti-tumor bispecific antibodies based on breakthrough discoveries in molecular biology, enabling patients with major diseases to obtain more efficient treatment solutions.
YZY BIO
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Product Research
Founded:
2010-07-01
Address:
Wuhan, Hubei, China
Country:
China
Website Url:
http://www.yzybio.com
Total Employee:
51+
Status:
Active
Contact:
86 27 82668988
Email Addresses:
[email protected]
Total Funding:
450 M CNY
Similar Organizations
Astrogen
Astrogen is a biotech company developing new drugs.
Autotelic Bio
Autotelic Bio is a bio technology company that researches and develops anti-cancer drugs.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
TCR2
TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.
Current Employees Featured
Founder
Investors List
Wuhan Institute of Biotechnology
Wuhan Institute of Biotechnology investment in Series B - YZY Bio
BGI Co-Win
BGI Co-Win investment in Series B - YZY Bio
Sanhua Hongdao Investment
Sanhua Hongdao Investment investment in Series B - YZY Bio
TD Capital
TD Capital investment in Series B - YZY Bio
Official Site Inspections
http://www.yzybio.com
- Host name: 121.199.6.220
- IP address: 121.199.6.220
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "YZY Bio"
武汉友芝友生物制药
武汉友芝友生物制药股份有限公司是一家领先的、创新驱动的生物科技企业，专门从事双特异性抗体(BsAb)靶向和肿瘤免疫疗法，以解决肿瘤及老年病等大量未被满足的医疗需求。公司的使命 …See details»
公司介绍 - 关于我们 - 武汉友芝友生物制药 - YZY Bio
武汉友芝友生物制药股份有限公司成立于2010年，是一家致力于开发双特异性抗体(BsAb)疗法的生物技术公司。公司已前瞻性布局包括但不限于肿瘤并发症、肿瘤、眼科、自身免疫疾病等在内 …See details»
Company Overview - About YZYBIO - Wuhan YZY Biopharma Co., …
[email protected]. Home About YZYBIO Science and Technology Products and Research Investor Relations News Careers. Phone： 027-82668988 E-Mail：[email protected] …See details»
YZY Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 86 27 82668988 YZY Bio is a biotechnology company that develops anti-tumor bispecific antibodies based …See details»
Wuhan YZY Biopharma Co. Ltd. | LinkedIn
Wuhan YZY Biopharma Co. Ltd. YZY Biopharma is a biotech company whose vision is to develop new class of innovative medicines based on breakthrough discovery in molecular biology.See details»
Board of Directors - Corporate Governance - Investor Relations
Home About YZYBIO Science and Technology Products and Research Investor Relations News Careers. Phone： 027-82668988 E-Mail：[email protected] Address：Biolake, C2-1, No. 666 …See details»
公司治理 - 投资者关系 - 武汉友芝友生物制药 - yzybio.com
邮箱：[email protected] 地址：湖北省武汉市东湖新技术开发区高新大道666号光谷生物城C2-1栋See details»
Wuhan YZY Biopharma Co., Ltd. - Drug pipelines, Patents, Clinical ...
Explore Wuhan YZY Biopharma Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 18 clinical trials, 1 news, and 17 literature, Disease Domain:Neoplasms, Hemic and …See details»
Wuhan YZY Biopharma Co., Ltd.
了解Wuhan YZY Biopharma Co., Ltd. (武汉友芝友生物制药股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的18项临床试验, 1篇新闻和17篇文献，疾病领域:肿瘤，血液及淋巴 …See details»
Wuhan YZY Biopharma Company Description - Stock Analysis
Mar 11, 2025 Company profile for Wuhan YZY Biopharma Co., Ltd. (HKG:2496) with a description, list of executives, contact details and other key facts.See details»
Corporate Governance - Investor Relations - Wuhan YZY ... - YZY Bio
Email：[email protected]. Subscription Center. Home About YZYBIO Science and Technology Products and Research Investor Relations News Careers. Phone： 027-82668988 E …See details»
Wuhan YZY Biopharma Co., Ltd.-友芝友生物制药
Y2019 is a new recombinant SARS-CoV-2 subunit protein vaccine developed by YZYBIO in cooperation with Wuhan Institute of Virology in response to the COVID-19 pandemic. YZYBIO …See details»
YZY Bio 2025 Company Profile: Stock Performance & Earnings
YZY Bio General Information Description. Wuhan YZY Biopharma Co Ltd is a biotechnology company specifically involved in developing bispecific antibody-based therapies to treat cancer …See details»
业绩报告 - 信息披露 - 投资者关系 - 武汉友芝友生物制药
邮箱：[email protected] 地址：湖北省武汉市东湖新技术开发区高新大道666号光谷生物城C2-1栋See details»
研发中心 - 产品与研发 - 武汉友芝友生物制药 - YZY Bio
邮箱：[email protected] 地址：湖北省武汉市东湖新技术开发区高新大道666号光谷生物城C2-1栋See details»
RD Center - Products and Research - Wuhan YZY Biopharma Co., Ltd.
With the mission of "Develop innovative drugs to safeguard human health", YZYBIO has established a visionary and seasoned R&D team and an integrated research and development …See details»
在研产品 - 研发中心 - 产品与研发 - 武汉友芝友生物制药
主要用于治疗难治性或复发、难治性多发性骨髓瘤（rrMM）； 全球（不包括中国）和中国已分别有22种和9种用作治疗MM的CD38靶向抗体候选药物或融合蛋白处于临床开发阶段；See details»
Research Area - Science and Technology - YZY Bio
Y2019 is a new recombinant SARS-CoV-2 subunit protein vaccine developed by YZYBIO in cooperation with Wuhan Institute of Virology in response to the COVID-19 pandemic. YZYBIO …See details»
研究领域 - 科学技术 - 武汉友芝友生物制药 - YZY Bio
预防性疫苗是友芝友生物重要的研发领域之一。疫苗是针对病原体或对于病原体感染至关重要的蛋白（多肽、肽）、多糖或核酸，以一种或多种成分,直接或通过载体经免疫接种进入机体后,能 …See details»
Products - RD Center - Products and Research - Wuhan YZY …
On July 26, 2022, YZYBIO entered into an asset transfer agreement with Shenzhen Kangzhe Vision Pharmaceutical Development Co.,Ltd. (深圳市康哲维盛医药发展有限责任公司)(“CMS …See details»